Myriad Genetics Inc (NASDAQ: MYGN) stock enjoyed a major increase of 11.3% on 9/11/25. The shares closed at $7.68. NORMAL trading volume accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 12.9% during the last week.
Current PriceTarget Research Rating
Myriad Genetics has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Myriad Genetics has a neutral Appreciation Score of 46 but a very low Power Rating of 8, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment